Efonidipine hydrochloride monoethanolate

CAS : 111011-76-8

Ref. 3D-BE179488

Informations sur le produit

• Nom: Efonidipine hydrochloride monoethanolate
• Synonymes: Hydrochloride, Efonidipine hydrochloride ethanolate, Efonidipine hydrochloride ethanol, Efonidipine HCl ethanolate, Ethanol, compd. with 2-(phenyl(phenylmethyl)amino)ethyl 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate P-oxide monohydrochloride (1:1), Ethanol, compd. with 2-(phenyl(phenylmethyl)amino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate monohydrochloride, NZ 105 ethanolate, Unii-3Br983K69O, 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-4-(3-nitrophenyl)-, 2-(phenyl(phenylmethyl)amino)ethyl ester, P-oxide, monohydrochloride, 3-Pyridinecarboxylic acid, 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(phenyl(phenylmethyl)amino)ethyl ester, monohydrochloride, compd. with ethanol (1, 1), 2-[Benzyl(Phenyl)Amino]Ethyl 5-(5,5-Dimethyl-2-Oxido-1,3,2-Dioxaphosphinan-2-Yl)-2,6-Dimethyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3-Carboxylate, 2-[Benzyl(Phenyl)Amino]Ethyl 5-(5,5-Dimethyl-2-Oxido-1,3,2-Dioxaphosphinan-2-Yl)-2,6-Dimethyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3-Carboxylate - Ethanol Hydrochloride (1:1:1)
• CAS: 111011-76-8

Description

Efonidipine hydrochloride monoethanolate is a calcium channel blocker that blocks voltage-dependent calcium channels. It has been shown to reduce the incidence of bowel disease in humans, and is used to treat high blood pressure and heart failure. Efonidipine hydrochloride monoethanolate can be administered orally, intravenously, or by injection. The drug has been shown to have an effect on the concentration-time curve of maternal blood glucose levels in pregnant women with diabetes mellitus type 1. Efonidipine hydrochloride monoethanolate also may cause drug interactions with other drugs that are metabolized by cytochrome P450 enzymes. It will bind to matrix proteins in atherosclerotic lesions and inhibit light-induced fluorescence. This drug can be used as an analytical tool for measuring concentrations of various substances in the body fluids of patients with metabolic disorders such as diabetes mellitus type 1 or 2, hyperlipidaemia, hypertension

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 714.18 g/mol
• Formule: C₃₆H₄₅ClN₃O₈P
• Degré de pureté: Min. 95%